全文获取类型
收费全文 | 226065篇 |
免费 | 17489篇 |
国内免费 | 762篇 |
专业分类
耳鼻咽喉 | 2445篇 |
儿科学 | 5988篇 |
妇产科学 | 4777篇 |
基础医学 | 29308篇 |
口腔科学 | 4869篇 |
临床医学 | 21869篇 |
内科学 | 47663篇 |
皮肤病学 | 2932篇 |
神经病学 | 21992篇 |
特种医学 | 7634篇 |
外国民族医学 | 13篇 |
外科学 | 35501篇 |
综合类 | 3734篇 |
现状与发展 | 2篇 |
一般理论 | 304篇 |
预防医学 | 20660篇 |
眼科学 | 4618篇 |
药学 | 15486篇 |
1篇 | |
中国医学 | 380篇 |
肿瘤学 | 14140篇 |
出版年
2023年 | 820篇 |
2021年 | 3688篇 |
2020年 | 2255篇 |
2019年 | 3641篇 |
2018年 | 4246篇 |
2017年 | 3429篇 |
2016年 | 3655篇 |
2015年 | 4316篇 |
2014年 | 6470篇 |
2013年 | 9454篇 |
2012年 | 13904篇 |
2011年 | 15178篇 |
2010年 | 8544篇 |
2009年 | 7792篇 |
2008年 | 14310篇 |
2007年 | 15208篇 |
2006年 | 14663篇 |
2005年 | 15209篇 |
2004年 | 14561篇 |
2003年 | 13626篇 |
2002年 | 13113篇 |
2001年 | 2478篇 |
2000年 | 2097篇 |
1999年 | 2637篇 |
1998年 | 3069篇 |
1997年 | 2640篇 |
1996年 | 2412篇 |
1995年 | 2126篇 |
1994年 | 1944篇 |
1993年 | 1767篇 |
1992年 | 1587篇 |
1991年 | 1559篇 |
1990年 | 1441篇 |
1989年 | 1357篇 |
1988年 | 1318篇 |
1987年 | 1341篇 |
1986年 | 1314篇 |
1985年 | 1366篇 |
1984年 | 1669篇 |
1983年 | 1616篇 |
1982年 | 1928篇 |
1981年 | 1738篇 |
1980年 | 1637篇 |
1979年 | 986篇 |
1978年 | 1097篇 |
1977年 | 1036篇 |
1976年 | 941篇 |
1975年 | 773篇 |
1974年 | 828篇 |
1973年 | 716篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
991.
992.
Debra L Ellies Beth Viviano John McCarthy Jean-Philippe Rey Nobue Itasaki Scott Saunders Robb Krumlauf 《Journal of bone and mineral research》2006,21(11):1738-1749
We compared and contrasted the mechanism of action for the cysteine knot protein subfamily, Wise and Sost (Sclerostin). Our data suggest that functional interactions between Sost or Wise and LRP5/LRP6 have the potential to regulate bone deposition by modulating the Wnt pathway. INTRODUCTION: The human disease sclerosteosis exhibits an increase in bone mass thought to be caused by hyperactive osteoblasts. Sclerostin, SOST, the gene affected in this disease, has been postulated to exert its activity by functioning as a BMP antagonist. However, recent evidence indicates that SOST is highly related to Wise, which can also modulate the Wnt pathway by binding to LRP5 and LRP6. MATERIALS AND METHODS: For this study, we used cell culture to test the BMP and Wnt activity function of both Wise and Sost. In addition, we used Xenopus in vivo Wnt assays along with Xenopus in vitro Wnt assays to support our cell culture results. Epitope tagged cell supernatants containing either Sost or soluble mutant or wildtype LRP5/LRP6 were used for immunoprecipitation. Sost immunoprecipitation results were confirmed in vivo using cell culture. Finally, to support our in vitro data, we co-localized Sost, Wise, LRP5, and LRP6 in mouse long bone sections. Results: In this study, we report in vitro and in vivo evidence to show that Sost physically interacts with Lrp5 and Lrp6 and inhibits the canonical Wnt signaling pathway. Furthermore, using in vitro and in vivo assays, we showed that a variant of LRP5 (LRP5(G171V)) known to cause the human high bone mass (HBM) trait and a homologous change in LRP6 (LRP6(G158V)) abolished protein interactions with Sost. We used variants of Sost amino acids to further identify the contact points between Sost and LRP6. In Xenopus and mammalian cell culture assays, we showed that SOST is able to attenuate Wnt signaling and that this attenuation can be rescued by the addition of alpha-Sost antibodies or by the introduction of single amino acid substitution that alter its binding to LRP6. Sost differs from Wise in that it is unable to stimulate Wnt signaling. Using immunohistochemistry, we found that Sost and Wise are co-localized to osteoblasts, along with LRP5 and LRP6. CONCLUSIONS: Our data suggest that functional interactions between Sost or Wise and LRPs have the potential to regulate bone deposition by modulating Wnt signaling. 相似文献
993.
994.
995.
996.
997.
998.
999.
John S March Martin E Franklin Henrietta Leonard Abbe Garcia Phoebe Moore Jennifer Freeman Edna Foa 《Neuropsychopharmacology》2007,61(3):344-347
BACKGROUND: The presence of a comorbid tic disorder may predict a poorer outcome in the acute treatment of pediatric obsessive-compulsive disorder (OCD). METHODS: Using data from the National Institute of Mental Health (NIMH)-funded Pediatric OCD Treatment Study (POTS) that compared cognitive-behavior therapy (CBT), medical management with sertraline (SER), and the combination of CBT and SER (COMB), to pill placebo (PBO) in children and adolescents with OCD, we asked whether the presence of a comorbid tic disorder influenced symptom reduction on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) after 12 weeks of treatment. RESULTS: Fifteen percent (17 of 112) of patients exhibited a comorbid tic disorder. In patients without tics, results replicated previously published intent-to-treat outcomes: COMB > CBT > SER > PBO. In patients with a comorbid tic disorder, SER did not differ from PBO, while COMB remained superior to CBT and CBT remained superior to PBO. CONCLUSIONS: In contrast to CBT outcomes, which are not differentially impacted, tic disorders appear to adversely impact the outcome of medication management of pediatric OCD. Children and adolescents with obsessive-compulsive disorder and a comorbid tic disorder should begin treatment with cognitive-behavior therapy alone or the combination of cognitive-behavior therapy plus a serotonin reuptake inhibitor. 相似文献